.

FILTERS

Refine your search with the following facets to narrow down your results.

Content typeCompanies

28 matches for your search

Applied filters:Reset all filters
CompaniesBelgium
Sort by:

Companies: 28 Results

image description

Augustine Therapeutics

Belgium

Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 ...

image description

ATB Therapeutics

Belgium

atbtherapeutics is a pioneering biopharmaceutical company building a pipeline of weaponized antibodies. Those novel therapeutic formats can only be achieved using our proprietary plant-based atbiofarm technology.

antibodies
image description

4Tissue

Belgium

4Tissue is a biotech company at the forefront of regenerative medicine, utilizing advanced bio-interactive hydrogels to transition from cells to tissue engineering. Founded through a collaboration between Prof. Phillip Blondeel, a global leader in plastic and reconstructive surgery, and Prof. Dr. ...

hydrogels
image description

AmphiStar

Belgium

AmphiStar offers a portfolio of locally produced microbial biosurfactants to companies seeking to develop sustainable, performant & affordable products with surfactants as important performance ingredients. AmphiStars’ surfactants are part of a platform technology and are not linked to fossil ...

biosurfactants
image description

Obulytix

Belgium

The world is facing an unprecedented antimicrobial resistance crisis with regular antibiotics losing their efficacy against antibiotic-resistant bacteria. Obulytix is a biotechnology company focused on the discovery and development of a groundbreaking class of enzyme-based antibiotics to combat ...

antibiotics
image description

Amyl Therapeutics

Belgium

Amyl Therapeutics has developed a novel mechanism to conformationally bind to the amyloid fold of toxic protein aggregates of various types, causing neurodegenerative diseases or systemic amyloidosis diseases. The pan-amyloid binding and amyloid fibril remodeling capabilities of Amyl ...

image description

Bioxodes

Belgium

Bioxodes specializes in the development of novel therapies for the prevention and treatment of thrombotic and inflammatory diseases. Since its founding in 2013, Bioxodes has developed its own flagship program based around its Ir-CPI molecule. Ir-CPI is a first-in-class drug candidate aimed at ...

drug design
image description

Agomab Therapeutics NV

Belgium

Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. By combining new scientific insights with robust drug development and a long-term corporate vision, we are ...

drug design
image description

BIO INX

Belgium

BIO INX® is a spin-off company of Ghent University and Vrije Universiteit Brussel focusing on the commercialisation of materials and bio-inks for 3D bioprinting or biofabrication by utilizing decades of academic experience in the field of polymers and biomaterials. By offering a unique material ...

3D printing materials biomaterials inks
image description

Santero Therapeutics SRL

Belgium

Santero Therapeutics SRL is a spin-off biotech from the Université Libre de Bruxelles founded in 2021 by Professors Cédric Govaerts, PhD and Abel Garcia-Pino, PhD The company is anchored in more than a decade of fundamental research carried out in the labs of the Founders. Santero Therapeutics ...

antibiotics antimicrobial drugs